AI assistant
Poly Medicure Ltd — Capital/Financing Update 2026
Apr 30, 2026
60661_rns_2026-04-30_ca885546-a6ee-45bd-a7ba-12fc89f17e6d.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Poly Medicure Limited
Regd. Office: 232 B, 3rd Floor, Okhla Industrial Estate,
Phase-III, New Delhi - 110 020 (INDIA)
T: +91-11-33550700, 47317000
E: [email protected] W: polymedicure.com
CIN: L 40300DL1995PLC066923
POLYMED
Date: 30th April, 2026
Scrip Code: - 531768
The Manager,
BSE Limited,
Department of Corporate Services,
Phirozee Jeejeebhoy Towers,
Dalal Street, Mumbai- 400001.
Scrip Code:- POLYMED
The Manager
National Stock Exchange of India Limited
Exchange Plaza, Plot No. C/1-Block-G
Bandra Kurla Complex, Bandra(E),
Mumbai-400051.
Subject : Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Acquisition of Subsidiary
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that Polymed Brazil LTDA a wholly Owned Subsidiary of Poly Medicure Limited (“the Company”) has executed a Quota (Share) Purchase Agreement on 29th April, 2026 with the Quotaholders (Shareholders) of “MEDYNEO COMERCIO DE PRODUTOS PARA SAUDE LTDA” (“MEDYNEO”) for acquisition of 100% equity in the company.
On the same day Polymed Brazil LTDA, has completed the acquisition process and taken over the operational control of MEDYNEO and consequently, MEDYNEO has become a wholly owned subsidiary of Polymed Brazil LTDA and a step-down subsidiary of the Poly Medicure Limited effective April 29, 2026. Information in this regard has been received by the Company on April 30, 2026 at 6.00 P.M.
The details of the above acquisition (as required to be furnished pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI Listing Regulations and SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated 30th January, 2026) are as under:
Kindly take note of the same for your further needful and oblige us.
Thanking You,
Yours Sincerely
For Poly Medicure Limited
AVINASH
CHANDR
A
Digitally signed by AVINASH CHANDRA
Date: 2026.04.30 19:34:53 +05'30'

Avinash Chandra
Company Secretary
M. No. A32270
Plants : Plot No.104-105 & 115-116-117, Sector-59, HSIIDC Industrial Area, Ballabgarh, Faridabad - 121004, Haryana (INDIA)
Plot No. 33-34, Sector-68, IMT, Faridabad-121004, (Haryana) INDIA T: +91-129-4287000, 3355070
Annexure - A
Details as required under SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated 30th January, 2026.
| S. No. | Particular | Details |
|---|---|---|
| a. | Name of the target entity, details in brief such as size, turnover etc. | Name: MEDYNEO COMERCIO DE PRODUTOS PARA SAUDE LTDA |
| Business of the Target: Importation and commercialization of medical devices | ||
| Authorized Capital: Brazilian Reais (R$) 20,000 | ||
| Paid UP Share Capital: . Brazilian Reais (R$) 20,000 | ||
| Turnover of the Target: 25-26 - Nil | ||
| b. | Whether the acquisition would fall within related party transaction(s) and whether the promoter/promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at “arm’s length” | No |
| c. | Industry to which the entity being acquired belongs | Medical Devices |
| d. | Objects and impact of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity) | The acquisition of the Target company provides access to all the necessary operating licenses for Polymed Brazil LTDA to commercialize the business in Brazil including importation and distribution of Medical Devices. |
| e. | Brief details of any governmental or regulatory approvals required for the acquisition | Not required |
S
| f. | Indicative time period for completion of the acquisition; | Completed the acquisition on April 30, 2026 |
|---|---|---|
| g. | Nature of Consideration - whether cash consideration or share swap or any other form and details of the same | Cash Consideration |
| h. | Cost of acquisition and/or the price at which the shares are acquired | The total consideration for acquisition of the Target is Brazilian Reais (R$)180,000 |
| i. | Percentage of shareholding / control acquired and / or number of shares acquired | Acquisition of 100% equity stake of MEDYNEO COMERCIO DE PRODUTOS PARA SAUDE LTDA |
| j. | Brief background about the entity acquired in terms of products/line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief) | MendyNeo a limited liability company without past activities, operations, employees or liabilities of any kind, which holds all licenses, permits and registrations required for it to legally operate in Brazil in the business segment of importation and commercialization of medical devices. |
Company does not have any operations currently and was registered on July 24,2025
Country in which the acquired entity has presence and any other significant information:
Brazil |
